Jung A Eom

401 total citations · 1 hit paper
11 papers, 245 citations indexed

About

Jung A Eom is a scholar working on Epidemiology, Molecular Biology and Physiology. According to data from OpenAlex, Jung A Eom has authored 11 papers receiving a total of 245 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 9 papers in Molecular Biology and 3 papers in Physiology. Recurrent topics in Jung A Eom's work include Liver Disease Diagnosis and Treatment (11 papers), Gut microbiota and health (9 papers) and Diet and metabolism studies (3 papers). Jung A Eom is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Gut microbiota and health (9 papers) and Diet and metabolism studies (3 papers). Jung A Eom collaborates with scholars based in South Korea. Jung A Eom's co-authors include Dong Joon Kim, Haripriya Gupta, Ki Tae Suk, Satya Priya Sharma, Sung‐Min Won, Jin‐Ju Jeong, Sang Jun Yoon, Hyojin Park, Byeong Hyun Min and Ki‐Kwang Oh and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Gut Microbes.

In The Last Decade

Jung A Eom

10 papers receiving 243 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gut microbiota-derived indole compounds attenuate metabolic dysfunction-associated steatotic liver disease by improving fat metabolism and inflammation

2024 69 citations Byeong Hyun Min, Haripriya Gupta et al. Gut Microbes profile →

Peers

Jung A Eom

MB

EPIDE

PHYSI

HEPAT

EDM

Na Young Lee South Korea

Qian Song China

Byeong Hyun Min South Korea

Jason D. Kang United States

Olena Tsyryuk Ukraine

Angélica Hernández-Arriaga Germany

Zeshi Liu China

C Kunst Germany

Andreas Blesl Austria

Na Young Lee South Korea

Jung A Eom

171 ×1.3

MB

143 ×1.2

EPIDE

58 ×0.9

PHYSI

54 ×1.2

HEPAT

26 ×0.9

EDM

Citations per year, relative to Jung A Eom Jung A Eom (= 1×) peers Na Young Lee

Countries citing papers authored by Jung A Eom

Since Specialization

Citations

This map shows the geographic impact of Jung A Eom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jung A Eom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jung A Eom more than expected).

Fields of papers citing papers by Jung A Eom

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jung A Eom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jung A Eom. The network helps show where Jung A Eom may publish in the future.

Co-authorship network of co-authors of Jung A Eom

This figure shows the co-authorship network connecting the top 25 collaborators of Jung A Eom. A scholar is included among the top collaborators of Jung A Eom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jung A Eom. Jung A Eom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Park, Jeong Ha, Min Ju Kim, Jung A Eom, et al.. (2025). Synbiotic combination of fructooligosaccharides and probiotics ameliorates the metabolic dysfunction-associated steatotic liver disease. The Journal of Microbiology. 63(2). e2411002–e2411002. 2 indexed citations

2.

Yoon, Sang Jun, Jieun Choi, Sung‐Min Won, et al.. (2025). Probiotic-Derived Strain-Specific Metabolites Ameliorate Metabolic Dysfunction–Associated Steatotic Liver Disease through Modulation of the Gut-Liver Axis. Probiotics and Antimicrobial Proteins.

3.

Sharma, Satya Priya, Haripriya Gupta, Sangyoon Lee, et al.. (2024). Gut microbiome and metabolome signatures in liver cirrhosis-related complications. Clinical and Molecular Hepatology. 30(4). 845–862. 13 indexed citations

4.

Min, Byeong Hyun, Haripriya Gupta, Jin‐Ju Jeong, et al.. (2024). Gut microbiota-derived indole compounds attenuate metabolic dysfunction-associated steatotic liver disease by improving fat metabolism and inflammation. Gut Microbes. 16(1). 69 indexed citations breakdown →

5.

Oh, Ki‐Kwang, Haripriya Gupta, Byeong Hyun Min, et al.. (2023). The identification of metabolites from gut microbiota in NAFLD via network pharmacology. Scientific Reports. 13(1). 724–724. 14 indexed citations

6.

Eom, Jung A, Jin‐Ju Jeong, Sang Hak Han, et al.. (2023). Gut-microbiota prompt activation of natural killer cell on alcoholic liver disease. Gut Microbes. 15(2). 2281014–2281014. 24 indexed citations

7.

Won, Sung‐Min, Ki‐Kwang Oh, Haripriya Gupta, et al.. (2022). The Link between Gut Microbiota and Hepatic Encephalopathy. International Journal of Molecular Sciences. 23(16). 8999–8999. 35 indexed citations

8.

Min, Byeong Hyun, Ye Rin Choi, Hyojin Park, et al.. (2022). Food and Gut Microbiota-Derived Metabolites in Nonalcoholic Fatty Liver Disease. Foods. 11(17). 2703–2703. 7 indexed citations

9.

Jeong, Jin‐Ju, Hyojin Park, Min Gi, et al.. (2022). The Lactobacillus as a Probiotic: Focusing on Liver Diseases. Microorganisms. 10(2). 288–288. 43 indexed citations

10.

Eom, Jung A, Na Yeon Kim, Eun Ju Park, et al.. (2021). Diet-Regulating Microbiota and Host Immune System in Liver Disease. International Journal of Molecular Sciences. 22(12). 6326–6326. 13 indexed citations

11.

Gebru, Yoseph Asmelash, Haripriya Gupta, Jung A Eom, et al.. (2021). T Cell Subsets and Natural Killer Cells in the Pathogenesis of Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences. 22(22). 12190–12190. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact